These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Comparative studies of huperzine A, E2020, and tacrine on behavior and cholinesterase activities. Cheng DH; Tang XC Pharmacol Biochem Behav; 1998 Jun; 60(2):377-86. PubMed ID: 9632220 [TBL] [Abstract][Full Text] [Related]
4. Long-lasting antiamnesic effect of a novel anticholinesterase inhibitor (MF268). Braida D; Paladini E; Griffini P; Lamperti M; Colibretti L; Sala M Pharmacol Biochem Behav; 1998 Apr; 59(4):897-901. PubMed ID: 9586846 [TBL] [Abstract][Full Text] [Related]
5. An inverted U-shaped curve for heptylphysostigmine on radial maze performance in rats: comparison with other cholinesterase inhibitors. Braida D; Paladini E; Griffini P; Lamperti M; Maggi A; Sala M Eur J Pharmacol; 1996 Apr; 302(1-3):13-20. PubMed ID: 8790986 [TBL] [Abstract][Full Text] [Related]
6. Donepezil, a centrally acting acetylcholinesterase inhibitor, alleviates learning deficits in hypocholinergic models in rats. Ogura H; Kosasa T; Kuriya Y; Yamanishi Y Methods Find Exp Clin Pharmacol; 2000 Mar; 22(2):89-95. PubMed ID: 10849891 [TBL] [Abstract][Full Text] [Related]
7. Reversal of scopolamine-induced spatial memory deficits in rats by TAK-147. Chen Z; Xu AJ; Li R; Wei EQ Acta Pharmacol Sin; 2002 Apr; 23(4):355-60. PubMed ID: 11931694 [TBL] [Abstract][Full Text] [Related]
8. Two novel 5-HT6 receptor antagonists ameliorate scopolamine-induced memory deficits in the object recognition and object location tasks in Wistar rats. de Bruin NM; Prickaerts J; van Loevezijn A; Venhorst J; de Groote L; Houba P; Reneerkens O; Akkerman S; Kruse CG Neurobiol Learn Mem; 2011 Sep; 96(2):392-402. PubMed ID: 21757018 [TBL] [Abstract][Full Text] [Related]
9. Effect of huperzine A, a novel acetylcholinesterase inhibitor, on radial maze performance in rats. Xiong ZQ; Tang XC Pharmacol Biochem Behav; 1995; 51(2-3):415-9. PubMed ID: 7667362 [TBL] [Abstract][Full Text] [Related]
10. Substituted Aminobenzothiazole Derivatives of Tacrine: Synthesis and Study on Learning and Memory Impairment in Scopolamine-Induced Model of Amnesia in Rat. Ahmadi A; Roghani M; Noori S; Nahri-Niknafs B Mini Rev Med Chem; 2019; 19(1):72-78. PubMed ID: 30009706 [TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of orally administered donepezil hydrochloride (E2020), a novel treatment for Alzheimer's disease, on cholinesterase activity in rats. Kosasa T; Kuriya Y; Matsui K; Yamanishi Y Eur J Pharmacol; 2000 Feb; 389(2-3):173-9. PubMed ID: 10688981 [TBL] [Abstract][Full Text] [Related]
12. Attenuation of scopolamine-induced deficits in navigational memory performance in rats by bis(7)-tacrine, a novel dimeric AChE inhibitor. Wang H; Carlier PR; Ho WL; Lee NT; Pang YP; Han YF Zhongguo Yao Li Xue Bao; 1999 Mar; 20(3):211-7. PubMed ID: 10452094 [TBL] [Abstract][Full Text] [Related]
13. Effects of novel tacrine-related cholinesterase inhibitors in the reversal of 3-quinuclidinyl benzilate-induced cognitive deficit in rats--Is there a potential for Alzheimer's disease treatment? Misik J; Korabecny J; Nepovimova E; Kracmarova A; Kassa J Neurosci Lett; 2016 Jan; 612():261-268. PubMed ID: 26708634 [TBL] [Abstract][Full Text] [Related]
14. Anticholinesterase effects of huperzine A, E2020, and tacrine in rats. Wang H; Tang XC Zhongguo Yao Li Xue Bao; 1998 Jan; 19(1):27-30. PubMed ID: 10375753 [TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of donepezil hydrochloride (E2020) on cholinesterase activity in brain and peripheral tissues of young and aged rats. Kosasa T; Kuriya Y; Matsui K; Yamanishi Y Eur J Pharmacol; 1999 Dec; 386(1):7-13. PubMed ID: 10611458 [TBL] [Abstract][Full Text] [Related]
16. The effects of novel 7-MEOTA-donepezil like hybrids and N-alkylated tacrine analogues in the treatment of quinuclidinyl benzilate-induced behavioural deficits in rats performing the multiple T-maze test. Misik J; Korabecny J; Nepovimova E; Cabelova P; Kassa J Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Dec; 159(4):547-53. PubMed ID: 25690521 [TBL] [Abstract][Full Text] [Related]
17. The scopolamine model as a pharmacodynamic marker in early drug development. Lenz RA; Baker JD; Locke C; Rueter LE; Mohler EG; Wesnes K; Abi-Saab W; Saltarelli MD Psychopharmacology (Berl); 2012 Mar; 220(1):97-107. PubMed ID: 21901320 [TBL] [Abstract][Full Text] [Related]
18. Effects of huperzine A on acetylcholinesterase isoforms in vitro: comparison with tacrine, donepezil, rivastigmine and physostigmine. Zhao Q; Tang XC Eur J Pharmacol; 2002 Nov; 455(2-3):101-7. PubMed ID: 12445575 [TBL] [Abstract][Full Text] [Related]
19. Huperzine A ameliorates the spatial working memory impairments induced by AF64A. Zhi QX; Yi FH; XI CT Neuroreport; 1995 Nov; 6(16):2221-4. PubMed ID: 8595207 [TBL] [Abstract][Full Text] [Related]
20. Ameliorative effects of azaindolizinone derivative ZSET845 on scopolamine-induced deficits in passive avoidance and radial-arm maze learning in the rat. Yamaguchi Y; Higashi M; Matsuno T; Kawashima S Jpn J Pharmacol; 2001 Nov; 87(3):240-4. PubMed ID: 11885975 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]